These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31026503)

  • 41. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? Alternatives to Implantable Cardiac Defibrillator Therapy for Brugada Syndrome.
    Belhassen B
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906651
    [No Abstract]   [Full Text] [Related]  

  • 42. To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
    Viskin S; Belhassen B; Wilde AA
    Heart Rhythm; 2010 Jun; 7(6):863. PubMed ID: 20226268
    [No Abstract]   [Full Text] [Related]  

  • 43. Short QT syndrome. Genotype-phenotype correlations.
    Borggrefe M; Wolpert C; Antzelevitch C; Veltmann C; Giustetto C; Gaita F; Schimpf R
    J Electrocardiol; 2005 Oct; 38(4 Suppl):75-80. PubMed ID: 16226079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. To the editor: response---Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
    Estes NA; Page RL
    Heart Rhythm; 2010 Jun; 7(6):863-4. PubMed ID: 20226275
    [No Abstract]   [Full Text] [Related]  

  • 45. Drugs to prevent sudden cardiac death.
    Erath JW; Hohnloser SH
    Int J Cardiol; 2017 Jun; 237():22-24. PubMed ID: 28341373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quinidine vs. ICD therapy in short-coupled ventricular fibrillation-is a randomized trial the next logical step?
    Steinberg C; Krahn AD
    Eur Heart J; 2021 Oct; 42(38):3993-3994. PubMed ID: 34480551
    [No Abstract]   [Full Text] [Related]  

  • 47. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 48. Radiofrequency Ablation of Asymptomatic Brugada Syndrome: Don't Go Burning My Heart.
    Viskin S
    Circulation; 2018 May; 137(18):1883-1884. PubMed ID: 29530885
    [No Abstract]   [Full Text] [Related]  

  • 49. Lateral "Coved" ST-Segment Elevation: Exceptional but Malignant Electrocardiographic Sign in a Patient with Brugada Syndrome.
    Kukla P; Szafran B; Pérez-Riera AR; Jastrzębski M; Baranchuk A
    Ann Noninvasive Electrocardiol; 2017 May; 22(3):. PubMed ID: 25363541
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of antiarrhythmic drugs on external fibrillation and defibrillation thresholds.
    KEMPEN RR; VAN HORN G
    Cardiovasc Res Cent Bull; 1963; 1():116-21. PubMed ID: 14031871
    [No Abstract]   [Full Text] [Related]  

  • 52. Ventricular fibrillation storm in a child.
    Einbinder T; Lowenthal A; Fogelman R
    Europace; 2014 Nov; 16(11):1654. PubMed ID: 25344961
    [No Abstract]   [Full Text] [Related]  

  • 53. Adverse effects of long-term therapeutic doses of quinidine in asymptomatic Brugada patients: should low doses be used first?
    Márquez MF; Tonet J
    Europace; 2014 Jul; 16(7):1100. PubMed ID: 24459248
    [No Abstract]   [Full Text] [Related]  

  • 54. Suppression of electrical storm by oral quinidine in a patient with Brugada syndrome.
    Haghjoo M; Arya A; Heidari A; Sadr-Ameli MA
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):674. PubMed ID: 15946371
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of ventricular fibrillation storm in Brugada syndrome: weathering the storm but staying in hot water?
    Shvilkin A
    Heart Rhythm; 2007 Jun; 4(6):701-2. PubMed ID: 17556187
    [No Abstract]   [Full Text] [Related]  

  • 56. Ionic basis of pharmacological therapy in Brugada syndrome.
    Márquez MF; Salica G; Hermosillo AG; Pastelín G; Gómez-Flores J; Nava S; Cárdenas M
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):234-40. PubMed ID: 17338775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Side effects could certainly be decreased with lower dose of quinidine in asymptomatic Brugada patients, but what about efficacy? Author reply.
    Bouzeman A; Leenhardt A
    Europace; 2014 Jul; 16(7):1100-1. PubMed ID: 24459247
    [No Abstract]   [Full Text] [Related]  

  • 58. [What remains of anti-arrhythmia drugs?].
    Lévy S
    Arch Mal Coeur Vaiss; 1993 Oct; 86(10):1501-5. PubMed ID: 8010849
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.
    Viskin S; Wilde AA; Tan HL; Antzelevitch C; Shimizu W; Belhassen B
    Heart Rhythm; 2009 Mar; 6(3):401-4. PubMed ID: 19251219
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.
    Belhassen B; Viskin S; Fish R; Glick A; Setbon I; Eldar M
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1301-12. PubMed ID: 10515552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.